Alternative Health Solutions for Thyroid Autoimmunity > Resources

Web Site Search

Friday, July 04, 2008

..:: Resources » Low-dose Naltrexone ::..

Low-dose Naltrexone / Page 1

Experimental Evidence for Immunomodulatory Effects of Opioids

Fibromyalgia Treatment: Stanford's Clinical Trial of Naltrexone Recruiting Patients

Inhibition of human colon cancer by intermittent opioid receptor blockade with naltrexone

Interview with LDN researcher Dr. Agrawal

LDNers.Org Research Page

Long-term Survival of Patient With Pancreatic Cancer (Berkson)

Low Dose Naltrexone Update: The Benefits of LDN in Autoimmune Disease

Low Dose Naltrexone: The Use of LDN for MS, Crohn's, and Other Autoimmune Diseases

Low-dose naltrexone therapy improves active Crohn's disease

MedInsight Announces Clinical Trial Results Of LDN; Potential Breakthrough For Crohn's

Naltrexone, a unique immune regulator showing promise in autoimmune diseases including HIV

Naltrexone, an Opioid Antagonist, Facilitates Reepithelialization of the Cornea in Diabetic Rat

On LDN in Crohn's Disease, Dr. Jill Smith (MP3)

Opioid antagonist modulation of murine neuroblastoma: a profile of cell proliferation and opioid pep

Opioid Growth Factor (Ogf) In Cancer Therapy

Peptides and Receptors in Development, Cancer, Cell Renewal... (Zagon)

The opioid antagonist naloxone induces a shift from Type 2 to Type 1 cytokine

UC San Francisco Study (completed): Effects of LDN in MS

Pages

LDN

page 1